Weiss Multi-Strategy Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,319	Closed	-$3.15M	–	615
2023 Q3	$3.15M	Sell	24,319 -681	-3%	-$90.7K	0.07%	309
2023 Q2	$3.1M	Sell	25,000 -9,398	-27%	-$1.26M	0.06%	385
2023 Q1	$5.03M	Buy	34,398 +24,398	+244%	+$3.61M	0.12%	263
2022 Q4	$1.59M	Sell	10,000 -24,000	-71%	-$3.52M	0.05%	414
2022 Q3	$4.53M	Buy	34,000 +6,029	+22%	+$917K	0.12%	257
2022 Q2	$4.36M	Buy	27,971 +9,065	+48%	+$1.4M	0.13%	241
2022 Q1	$2.94M	Buy	+18,906	New	+$2.74M	0.07%	339

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Weiss Multi-Strategy Advisers's JAZZ Position: Q4 2023 in Review

Weiss Multi-Strategy Advisers sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 24,319 shares — an estimated $3.15M sold.

Weiss Multi-Strategy Advisers first reported a position in JAZZ in Q1 2022 and held it in 7 quarters. The position peaked at $5.03M in Q1 2023. 499 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

Weiss Multi-Strategy Advisers reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 24,319 Jazz Pharmaceuticals shares in Q4 2023, an estimated $3.15M.
Weiss Multi-Strategy Advisers first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Jazz Pharmaceuticals position peaked at $5.03M in Q1 2023.
499 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.